CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $4.63 billion. The enterprise value is $2.97 billion.
| Market Cap | 4.63B |
| Enterprise Value | 2.97B |
Important Dates
The next estimated earnings date is Monday, August 3, 2026, after market close.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 98.48 million shares outstanding. The number of shares has increased by 8.27% in one year.
| Current Share Class | 98.48M |
| Shares Outstanding | 98.48M |
| Shares Change (YoY) | +8.27% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 78.00% |
| Float | 98.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,127.90 |
| Forward PS | 67.55 |
| PB Ratio | 2.50 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 724.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.96, with a Debt / Equity ratio of 0.43.
| Current Ratio | 17.96 |
| Quick Ratio | 17.92 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.21% and return on invested capital (ROIC) is -351.37%.
| Return on Equity (ROE) | -31.21% |
| Return on Assets (ROA) | -14.06% |
| Return on Invested Capital (ROIC) | -351.37% |
| Return on Capital Employed (ROCE) | -21.24% |
| Weighted Average Cost of Capital (WACC) | 11.63% |
| Revenue Per Employee | $10,440 |
| Profits Per Employee | -$1.45M |
| Employee Count | 393 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.36 million in taxes.
| Income Tax | 3.36M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.85% in the last 52 weeks. The beta is 1.70, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | -27.85% |
| 50-Day Moving Average | 52.89 |
| 200-Day Moving Average | 55.11 |
| Relative Strength Index (RSI) | 35.16 |
| Average Volume (20 Days) | 1,750,186 |
Short Selling Information
The latest short interest is 20.40 million, so 20.71% of the outstanding shares have been sold short.
| Short Interest | 20.40M |
| Short Previous Month | 26.57M |
| Short % of Shares Out | 20.71% |
| Short % of Float | 20.80% |
| Short Ratio (days to cover) | 11.93 |
Income Statement
In the last 12 months, CRSP had revenue of $4.10 million and -$568.53 million in losses. Loss per share was -$6.15.
| Revenue | 4.10M |
| Gross Profit | -478.71M |
| Operating Income | -550.14M |
| Pretax Income | -565.17M |
| Net Income | -568.53M |
| EBITDA | -531.08M |
| EBIT | -550.14M |
| Loss Per Share | -$6.15 |
Balance Sheet
The company has $2.44 billion in cash and $787.64 million in debt, with a net cash position of $1.65 billion or $16.80 per share.
| Cash & Cash Equivalents | 2.44B |
| Total Debt | 787.64M |
| Net Cash | 1.65B |
| Net Cash Per Share | $16.80 |
| Equity (Book Value) | 1.81B |
| Book Value Per Share | 18.83 |
| Working Capital | 2.31B |
Cash Flow
In the last 12 months, operating cash flow was -$399.96 million and capital expenditures -$1.21 million, giving a free cash flow of -$401.18 million.
| Operating Cash Flow | -399.96M |
| Capital Expenditures | -1.21M |
| Depreciation & Amortization | 19.06M |
| Net Borrowing | 600.00M |
| Free Cash Flow | -401.18M |
| FCF Per Share | -$4.07 |
Margins
| Gross Margin | n/a |
| Operating Margin | -13,408.29% |
| Pretax Margin | -13,774.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.27% |
| Shareholder Yield | -8.27% |
| Earnings Yield | -12.29% |
| FCF Yield | -8.67% |
Analyst Forecast
The average price target for CRSP is $84.70, which is 80.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $84.70 |
| Price Target Difference | 80.25% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 469.26% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 2.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 2 |